ITOSiTeos Therapeutics, Inc.

Nasdaq iteostherapeutics.com


$ 12.32 $ -0.10 (-0.81 %)    

Tuesday, 07-May-2024 15:59:55 EDT
QQQ $ 440.32 $ 0.07 (0.02 %)
DIA $ 388.70 $ 0.29 (0.07 %)
SPY $ 517.26 $ 0.57 (0.11 %)
TLT $ 90.79 $ 0.55 (0.61 %)
GLD $ 214.23 $ -0.99 (-0.46 %)
$ 12.31
$ 12.20
$ 0.00 x 0
$ 12.33 x 100
$ 12.00 - $ 12.54
$ 8.20 - $ 18.24
213,627
na
440.25M
$ 0.85
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-06-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-10-2023 03-31-2023 10-Q
5 03-15-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-10-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-23-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-11-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-24-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 09-01-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jp-morgan-maintains-overweight-on-iteos-therapeutics-lowers-price-target-to-27

JP Morgan analyst Brian Cheng maintains ITeos Therapeutics (NASDAQ:ITOS) with a Overweight and lowers the price target from ...

 hc-wainwright--co-reiterates-buy-on-iteos-therapeutics-maintains-44-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ITeos Therapeutics (NASDAQ:ITOS) with a Buy and maintains ...

 iteos-therapeutics-q4-eps-085-beats-103-estimate-cash-and-investment-position-of-6327m-is-expected-to-provide-cash-runway-through-2026

ITeos Therapeutics (NASDAQ:ITOS) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(...

 iteos-to-highlight-preclinical-data-on-first-in-class-eos-984-targeting-ent1-at-the-american-association-for-cancer-research-annual-meeting-2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of ...

 iteos-announces-2024-strategic-priorities-and-anticipated-milestones-cash-balance-and-investment-balance-of-6449m-as-of-september-30-2023-expected-to-provide-runway-through-2026

- TIGIT program clinical data readouts anticipated in 2024, including two Phase 2 trials assessing belrestotug + dostarlimab ...

 jp-morgan-maintains-overweight-on-iteos-therapeutics-lowers-price-target-to-29

JP Morgan analyst Daniel Wolle maintains ITeos Therapeutics (NASDAQ:ITOS) with a Overweight and lowers the price target from...

 iteos-therapeutics-q3-eps-090-beats-120-estimate-cash-cash-equivalents-and-investments-position-was-6449m-expected-to-provide-runway-through-2026

ITeos Therapeutics (NASDAQ:ITOS) reported quarterly losses of $(0.90) per share which beat the analyst consensus estimate of $(...

 wedbush-reiterates-outperform-on-iteos-therapeutics-maintains-33-price-target

Wedbush analyst David Nierengarten reiterates ITeos Therapeutics (NASDAQ:ITOS) with a Outperform and maintains $33 price tar...

 why-servisfirst-bancshares-shares-are-trading-lower-by-6-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent...

 wyndham-hotels--resorts-olink-holding-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in t...

 over-5m-bet-on-asana-check-out-these-3-stocks-insiders-are-buying

Although U.S. stocks closed lower on Thursday following the CPI data, there were a few notable insider trades.

 stocks-that-hit-52-week-lows-on-tuesday

  Tuesday saw 132 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 647 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-monday

  On Monday, 369 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-thursday

  During Thursday's session, 406 companies made new 52-week lows.

 who-are-other-players-gaining-from-roches-accidental-lung-cancer-data-update

Earlier today, Roche Holdings AG (OTC: RHHBY) announced that it had been made aware of inadvertent disclosure of the second int...

 sp-500-gains-1-analog-devices-posts-downbeat-results

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Wednesday. The ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION